A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee.

Saved in:
Bibliographic Details
Title: A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee.
Authors: Mino-Kenudson M; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: mminokenudson@mgb.org., Berezowska S; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Minami Y; Department of Pathology, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities, Tokai, Japan., Chen S; St Jude Children's Research Hospital, Memphis, Tennessee., Ray MA; School of Public Health, University of Memphis, Memphis, Tennessee., Rerkpichaisuth V; Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Hashisako M; Diagnostic Pathology, Kyushu University Hospital, Fukuoka, Japan., Losmanova T; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Hayashi T; Department of Human Pathology, Juntendo University Faculty of Medicine, Tokyo, Japan., Shim HS; Department of Pathology, College of Medicine, Yonsei University, Seoul, Republic of Korea., Righi L; Pathology Unit, San Luigi Hospital, Department of Oncology, University of Turin, Torino, Italy., Gagné A; Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval, Quebec City, Quebec, Canada., Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Bubendorf L; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Lopez-Rios F; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Matsubara D; Department of Pathology, University of Tsukuba, Tsukuba, Japan., von der Thüsen J; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Lantuejoul S; Université de Grenoble Alpes, Grenoble and Department of Pathology, Centre Leon Berard, Lyon, France., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Nicholson A; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom., Jain D; Department of Pathology, AIIMS, New Delhi India and Thoracic Pathology Center of Excellence, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Han Y; Department of Pathology, Shanghai Chest Hospital, Shanghai, China., Wynes MW; International Association for the Study of Lung Cancer, Denver, Colorado., Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Smeltzer MP; School of Public Health, University of Memphis, Memphis, Tennessee., Cooper WA; Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, Australia., Papotti MG; Department of Oncology, University of Turin, Torino, Italy.
Corporate Authors: IASLC Pathology Committee Members
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Feb; Vol. 21 (2), pp. 294-309. Date of Electronic Publication: 2025 Sep 30.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2025.09.1761